Rocha, Riden V.
HRN: 13-41-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2022
CEFTRIAXONE 1G (VIAL)
05/26/2022
06/01/2022
IVT
1g
Q12
T/c Meningitis
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes